
Agile Therapeutics AGRX
Quartalsbericht 2024-Q2
hinzugefügt 12.08.2024
Agile Therapeutics P/S 2011-2026 | AGRX
P/S Jährlich Agile Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.066 | 0.0238 | 0.165 | 329 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 329 | 0.0238 | 82.4 |
P/S anderer Aktien in der Arzneimittelhersteller
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M | ||
|
Alimera Sciences
ALIM
|
1.26 | - | - | $ 142 M | ||
|
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
3.78 | - | 0.86 % | $ 117 M | ||
|
Canopy Growth Corporation
CGC
|
0.528 | $ 0.97 | 2.36 % | $ 104 M | ||
|
Aurora Cannabis
ACB
|
3.73 | $ 3.31 | 1.53 % | $ 86.3 M | ||
|
China Pharma Holdings
CPHI
|
1 | $ 0.63 | 16.11 % | $ 11 M | ||
|
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | ||
|
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
4.24 | - | - | $ 2.06 B | ||
|
Cronos Group
CRON
|
77.6 | $ 2.52 | 5.44 % | $ 1.31 B | ||
|
DURECT Corporation
DRRX
|
3.72 | - | - | $ 50.1 M | ||
|
Emergent BioSolutions
EBS
|
0.132 | $ 8.05 | -1.71 % | $ 412 M | ||
|
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
0.432 | - | - | $ 36.6 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
6.01 K | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
0.719 | - | 2.45 % | $ 38.1 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
8.49 | $ 3.05 | 7.77 % | $ 42.9 M | ||
|
Bausch Health Companies
BHC
|
0.386 | $ 5.1 | 1.8 % | $ 1.86 B | ||
|
Harrow Health
HROW
|
7.1 | $ 34.0 | 2.16 % | $ 1.25 B | ||
|
Assertio Holdings
ASRT
|
0.635 | $ 14.0 | 4.71 % | $ 89.6 M | ||
|
OptiNose
OPTN
|
2.7 | - | - | $ 1.08 B | ||
|
Evolus
EOLS
|
0.913 | $ 4.68 | 0.86 % | $ 302 M | ||
|
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | ||
|
Pacira BioSciences
PCRX
|
5.13 | $ 22.65 | 2.44 % | $ 1.05 B | ||
|
OrganiGram Holdings
OGI
|
4.82 | $ 1.36 | - | $ 402 M | ||
|
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | ||
|
PLx Pharma
PLXP
|
14.4 | - | -27.8 % | $ 2.56 M | ||
|
ProPhase Labs
PRPH
|
1.06 | - | - | $ 5.07 M | ||
|
Jupiter Wellness
JUPW
|
118 | - | - | $ 33.6 M | ||
|
Radius Health
RDUS
|
1.64 | - | - | $ 1.42 B | ||
|
Rockwell Medical
RMTI
|
0.424 | $ 1.02 | -2.86 % | $ 23.8 M | ||
|
Lannett Company
LCI
|
0.0823 | - | 1.15 % | $ 7.11 M | ||
|
Sundial Growers
SNDL
|
0.0158 | $ 1.36 | 0.74 % | $ 3.37 M | ||
|
SCYNEXIS
SCYX
|
1.84 | $ 0.88 | -6.09 % | $ 43.9 M | ||
|
Organogenesis Holdings
ORGO
|
0.86 | $ 2.47 | 3.65 % | $ 325 M | ||
|
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | ||
|
Perrigo Company plc
PRGO
|
0.461 | $ 9.57 | 3.46 % | $ 1.33 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
0.256 | $ 2.55 | 4.94 % | $ 3.16 M | ||
|
Tilray
TLRY
|
1.9 | $ 6.45 | 3.86 % | $ 3.99 B | ||
|
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | ||
|
TherapeuticsMD
TXMD
|
18.4 | $ 2.31 | 3.12 % | $ 24.1 M | ||
|
Veru
VERU
|
6.39 | $ 2.3 | 1.32 % | $ 310 M | ||
|
Viatris
VTRS
|
1.19 | $ 13.29 | 0.68 % | $ 16 B | ||
|
cbdMD
YCBD
|
0.0863 | $ 0.76 | 11.88 % | $ 3.28 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
895 | - | - | $ 55.5 M |